VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes

The VG161 represents the first recombinant oncolytic herpes simplex virus type 1 carrying multiple synergistic antitumor immuno‐modulating factors. Here, we report its antitumor mechanisms and thus provide firm theoretical foundation for the upcoming clinical application in pancreatic cancer. Genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yinan, Song, Wei, Lin, Danni, Zhang, Xiaozhen, Wang, Meng, Li, Yuwei, Yang, Zifan, Guo, Sida, Wang, Zijun, Sheng, Jianpeng, Murad, Yanal, Ding, Jun, Lou, Yufeng, Pan, Xinping, Wu, Zongsong, Zhao, Ronghua, Jia, Weiguo, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087349/
https://www.ncbi.nlm.nih.gov/pubmed/36042555
http://dx.doi.org/10.1002/jmv.28108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087349/
https://www.ncbi.nlm.nih.gov/pubmed/36042555
http://dx.doi.org/10.1002/jmv.28108

Ejemplares similares